Bangkok study aims to reduce chemsex risks among gay men

NCT ID NCT07512869

Recruiting now Knowledge-focused Sponsor: Institute of HIV Research and Innovation Foundation, Thailand Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is gathering information from men who have sex with men who take part in chemsex (using drugs before or during sex) in Bangkok, Thailand. Researchers will survey party hosts and guests about their drug use, sexual health, mental health, and experiences of stigma. The goal is to understand their needs and design a harm reduction program led by the community.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a community-driven harm reduction program that reduces substance use and sexual health risks among men who have sex with men in Bangkok.
What could go wrong: This is a small, early-stage study (76 participants) focused on gathering information, not testing a treatment. The findings may not apply to other cities or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chemsex Harm Reduction Psychological Well-Being sexually transmitted disease substance abuse substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREVENTION MENTAL HEALTH SEXUALLY TRANSMITTED INFECTIONS (STIS) SUBSTANCE USE

Contacts and locations

Locations

Tangerine Clinic, Institute of HIV Research and Innovation
RECRUITING

Pathum Wan, Bangkok, 10330, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.